CareValidate, a compliance infrastructure firm for telehealth manufacturers, introduced Thursday that it’s launching an expanded menopause/perimenopause hormone substitute remedy pathway.
CareValidate helps digital well being corporations, retailers and wellness manufacturers launch and scale digital care. It affords a licensed supplier community, pharmacy success and lab diagnostics. It helps applications for weight reduction, longevity, dermatology, erectile dysfunction and extra.
With the HRT pathway, CareValidate’s purchasers can launch hormone substitute choices, together with progesterone and estradiol, whereas counting on CareValidate’s supplier community and pharmacy success. HRT is commonly used to deal with menopause and replaces declining estrogen and progesterone ranges.
“Importantly, menopause care isn’t a one-time prescription,” mentioned Dr. Jiten Chhabra, co-founder and chief medical officer of CareValidate. “Girls’s wants change over time, and CareValidate’s infrastructure is designed to assist ongoing relationships, proactive follow-up, and remedy changes when clinically indicated. The target is to make healthcare really feel much less like a sequence of disconnected transactions and extra like having a devoted care workforce taking care of every affected person.”
A serious differentiator of the expanded providing is CareValidate’s AI-powered care brokers, Chhabra mentioned. These brokers act as 24/7 private healthcare concierges and assist sufferers schedule appointments, hold medical information updated, coordinate follow-ups and navigate care.
“Slightly than requiring sufferers to handle each step themselves, the brokers assist anticipate their wants and guarantee vital features of their care don’t fall by the cracks, whereas medical selections stay with licensed healthcare professionals,” Chhabra said.
Misinformation has traditionally led to a niche in entry to HRT. A 2002 examine on HRT falsely linked the remedy to breast most cancers. This examine has since been debunked, and in 2025, the FDA introduced that it’s eradicating black field warning labels from menopausal HRT merchandise.
Nonetheless, girls are nonetheless struggling to entry the remedy they want for menopause. About 80% of girls in menopause expertise sizzling flashes or evening sweats, in line with the Menopause Society. A Mayo Clinic examine estimates that menopause-related signs price the U.S. about $1.8 billion in misplaced work time.
“Our overarching aim is to assist extra individuals entry higher healthcare, sooner. In girls’s well being, which means enabling our companions to achieve extra sufferers, scale back pointless boundaries to care, and assist protected, evidence-based remedy over time,” Chhabra mentioned. “We additionally need to elevate the usual of care in cash-pay telehealth. Sufferers ought to anticipate the identical dedication to medical oversight, security, privateness, and continuity of care whether or not they use insurance coverage or pay straight.”
Photograph: Toa55, Getty Photos
